ArticleFrontiers in endocrinology2024

Development of a predictive nomogram for intermediate-risk differentiated thyroid cancer patients after fixed 3.7GBq (100mCi) radioiodine remnant ablation.

Lu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.